San Francisco, CA (PRWEB) March 17, 2015
November Research Group, LLC, a global leader in the delivery of medical product safety and pharmacovigilance services and software tools to pharmaceutical and life sciences organizations, today announced that the latest release of their WebReports software, version 3.2, went live with Oracle Argus Safety at Rho, a top full-service contract research organization headquartered in North Carolina.
Rho was one of the first companies to implement WebReports with Oracle Argus Safety. With the new version of WebReports released by November Research Group in December, Rho was able to upgrade and validate quickly and painlessly. WebReports 3.2 is more configurable and adds new features to the Line Listing and Cross Tabulation reports to empower Rho’s user community to meet even more of their ad hoc reporting requirements. The new version also continues to support Rho’s custom reporting requirements for ongoing projects.
“The true test of any software solution in our industry is its ability to support the needs of a Contract Research Organization because they have to support the needs of a variety of life sciences companies,” said Brad Gallien, Vice President of Product Development at November Research Group. “We are pleased that the release of our newest version of WebReports delivers additional functionality to Rho and continues to be an important component in their pharmacovigilance software suite.”
“November Research Group has remained closely engaged with us to ensure a successful implementation of this new version of WebReports while maintaining critical functions, such as our ongoing custom reporting needs,” said Victoria Williams, Director of Product Safety at Rho.
WebReports 3.2 is a fully configurable application, allowing companies to add or hide any fields, including user-defined flex fields, to reflect their adverse event case management process. The new version includes full localization in English and Japanese and continues to support Oracle Argus Safety, including the multi-tenant option, Oracle Argus Safety Japan, and Oracle Argus Insight. It also provides the ability for companies to develop their own custom reports and install them into the WebReports environment.
About November Research Group
November Research Group is a professional services firm that provides a complete spectrum of software and services in pharmacovigilance to the pharmaceutical and life science industry. The November Research Group team possesses extensive expertise spanning the entire pharmacovigilance industry including: implementation and support for the Oracle Argus Safety Suite, Oracle AERS, and other commercial adverse event reporting systems; requirements specification and system selection; custom software application and tool development; and, software validation. Our flagship software tools are designed to work seamlessly with both Argus Safety and AERS: PRIMO for the streamlined intake, review and triage of adverse events, product complaints and pregnancy registry cases; and WebReports for powerful on demand case search and visualization in English and Japanese. For more information, please visit our website at http://www.NovemberResearch.com, call (415) 987-3313, or email: info(at)novemberresearch(dot)com.
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 30 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit http://www.rhoworld.com and follow us on Twitter.
Celine Yuan, Marketing Specialist, November Research Group
T: (626) 322-4320 E: celine.yuan(at)novemberresearch(dot)com
Find More Environment Science Press Releases